Clinical Trial Update: Niraparib in High-grade Endometrial Cancer Trial [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 Niraparib trial for high-grade endometrial cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrial Serous Carcinoma
• Uterine Cancer

Drugs mentioned

• Niraparib (Zejula) (Niraparib)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Endometrial Cancer, Serous Adenocarcinoma | EARLY_Phase 1 | Status: WITHDRAWN